Dr Jonathan Sive is an expert haematologist based in London. He specialises in the diagnosis and management of blood cancers, with particular expertise in the treatment of myeloma. He is also highly experienced in the investigation of abnormal blood counts.
After qualifying, he completed specialist training in haematology at University College London Hospital and carried out a PhD at Cambridge University, where he investigated the use of genomic technologies to study the mechanisms of leukaemia development. He currently practises as a consultant haematologist at University College London Hospital, where he also has a private practice
Dr Sive is committed to research which improves treatment outcomes for all patients. In this respect, he is actively engaged in a variety of clinical research projects and takes a leading role in the development of national guidelines. His work has been widely published in numerous peer-reviewed journals and book chapters. He is also a member of the British Society for Haematology (BSH), the UK Myeloma Forum and the UK Myeloma Research Alliance, and is member of the executive committee of the UK Myeloma Forum.
A skilled clinician, Dr Sive combines his academic expertise in blood disorders with dedication to delivering an excellent standard of care to every patient. He is known for his clear and empathetic communication style and will explore all treatment options relevant to the patient’s circumstances in an honest and sensitive manner.